← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2002Last known activity
Oct 15, 2025
Timeline
1990s
- Jan 1, 1997
The Spectrum Health Group— Founded
Drugs by trial phase (48 distinct, 39 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Clostridium Infections
- Colitis, Ulcerative
- Communicable Diseases
- Crohn Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diverticulitis
- Fractures, Bone
- Glioma
- Graft vs Host Disease
- Hip Fractures
- Infections
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Medulloblastoma
- Multiple Myeloma
- Neck Pain
- Neoplasms, Plasma Cell
- Neuroblastoma
- Neurofibroma
- Neurofibromatoses
- Neurofibromatosis 1
- Pancreatic Neoplasms
- Polyps
- Postoperative Pain
- Urinary Bladder Neoplasms
Recent trials (50)
- NCT03581240Sponsor investigatorN/A—
- NCT03581240Lead sponsorN/A—
- NCT07076082OfficialPhase 4Oct 15, 2025
- NCT07076082Sponsor investigatorPhase 4Oct 15, 2025
- NCT07076082Lead sponsorPhase 4Oct 15, 2025
- NCT06422273Sponsor investigatorPhase 3Apr 16, 2024
- NCT06422273Lead sponsorPhase 3Apr 16, 2024
- NCT05367336Lead sponsorEarly Phase 1Aug 31, 2022
- NCT05065567Lead sponsorPhase 2Aug 30, 2021
- NCT05065528Lead sponsorN/AAug 30, 2021
- NCT04781673Sponsor investigatorPhase 4Apr 1, 2021
- NCT04781673Lead sponsorPhase 4Apr 1, 2021
- NCT05391893Lead sponsorPhase 4Jun 19, 2020
- NCT04301843Lead sponsorPhase 2Jun 1, 2020
- NCT04301843Sponsor investigatorPhase 2Jun 1, 2020
Details
- Founded
- Grand Rapids, MI, US Jan 1, 1997
- Last known activity
- Oct 15, 2025